Goldman Sachs (GS)

Goldman Sachs is the world's leading investment bank: the #1 investment bank in advisory, one of the largest FICC and equities trading desks, and an asset management business ($3.6bn AUS) growing as the durable fee stream. The transformation —the consumer-banking retreat (GreenSky, cards) to return to the core— de-risked the story and lifted ROTE to 16%. But it is a cyclical business by nature: 69% of revenue depends on capital markets, and EPS swings 2.6× across the cycle. The moat is reputational and talent-based, narrower than a universal bank's (without the low-cost deposit franchise).

A bank is valued on the equity —normalized P/E on net income to common plus price-to-tangible-book—, never on EV: deposits and debt are funding. The key for an investment bank is normalizing earnings to mid-cycle: today's (16.8% TTM ROTE, 21% in Q1'26) is at a capital-markets peak and inflated by one-offs (a −$1.1bn reserve release + a one-time tax benefit). Normalizing to a ~15% mid-cycle ROTCE (credit for the improved franchise, but without the peak), net income to common is ~$15.5bn.

At ~$1,055, that implies ~21× normalized earnings (and ~3× tangible book value, against its 1.2× historical median). The base scenario projects earnings growing modestly (~3%/year) with a buyback that reduces shares ~2%/year, and a disciplined exit multiple of ~12× P/E (equivalent to ~1.8× tangible book — a premium over the historical median for the improved franchise, but well below today's ~3×). That yields ~$762/share → a total return of -4%/year. Not even the bull scenario (sustained 16% ROTE + 14× premium multiple) clears today's price by a comfortable margin.

No margin of safety: the price already discounts a demanding scenario. At ~$1,055, at all-time highs, Goldman Sachs is a quality business priced for perfection — the textbook case of stacked optimism in a financial: peak earnings (capital markets booming + one-offs) multiplied by a peak multiple (~3× tangible book vs its 1.2× median). The verdict is Overvalued: the franchise has genuinely improved (exit from consumer, growing AWM, mid-teens ROTE), but the price discounts both the earnings peak AND the multiple peak holding at once. Normalizing earnings to mid-cycle with a disciplined multiple, the base ($762) sits well below the price, and even the bull scenario barely reaches it. There is no discount: no missing buyers or motivated sellers are identifiable — on the contrary, it is one of the most beloved stocks in the sector, at highs. The bear scenario (a capital-markets cycle downturn, with ROTE falling to ~11% and the multiple compressing to ~10× — as happened in 2022-2023) has a large downside. Value discipline says to wait for a cycle trough — not to buy an investment bank at the peak of both earnings and multiple at once.

Three things. The capital-markets cycle (the central disconfirmation test) — today's earnings are at an M&A/issuance/trading boom; an investment bank's EPS fell 60% from peak to trough in the 2021-2023 cycle, so the key metric is whether the cycle holds or reverses. The multiple — at ~3× tangible book (vs a 1.2× historical level), any earnings or cycle disappointment re-rates sharply; paying a premium multiple on peak earnings is a double risk. And governance — the $80M retention awards to Solomon and Waldron (with a strong shareholder backlash, say-on-pay at 66%), succession, and the litigation legacy (1MDB). At this price, the best entry point comes with a capital-markets cycle trough — not at highs with both earnings and multiple at their peak.